Delivery Order SPE2DB22D2006-SPE2DB25FW3KC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, valued at $17,849.85 under a Firm Fixed Price contract type. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside delivery against the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor...
- The Defense Logistics Agency awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) with an ultimate completion date of August 21, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $17,912.32 firm fixed-price delivery order is for the supply of OJJAARA 100 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 28, 2025 and is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The $17,212.75 order is for OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a completion date of March 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OJJAARA 200 MG TABLET UU 30S, with a ceiling value of $17,849.85 and a period of performance through February 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568062474 OJJAARA 200 MG TABLET UU 30S, with a ceiling value of $17,849.85. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3KCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in quantities of 30s, with a ceiling value of $35,699.72 under a firm fixed-price contract type. The delivery order, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience fulfilling pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.7k | 8/13/25 |